Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

3R17

hCarbonic anhydrase II bound to N-(2-fluoro.4-sulfamoylphenyl)-2-(thiophen-2-yl) acetamide

3R17 の概要
エントリーDOI10.2210/pdb3r17/pdb
関連するPDBエントリー3R16
分子名称Carbonic anhydrase 2, ZINC ION, GLYCEROL, ... (6 entities in total)
機能のキーワードreversible hydration of carbondioxide, lyase
由来する生物種Homo sapiens (human)
細胞内の位置Cytoplasm: P00918
タンパク質・核酸の鎖数1
化学式量合計29574.73
構造登録者
Biswas, S.,McKenna, R. (登録日: 2011-03-09, 公開日: 2011-05-25, 最終更新日: 2024-02-21)
主引用文献Biswas, S.,Aggarwal, M.,Guzel, O.,Scozzafava, A.,McKenna, R.,Supuran, C.T.
Conformational variability of different sulfonamide inhibitors with thienyl-acetamido moieties attributes to differential binding in the active site of cytosolic human carbonic anhydrase isoforms.
Bioorg.Med.Chem., 19:3732-3738, 2011
Cited by
PubMed Abstract: The X-ray crystal structures of the adducts of human carbonic anhydrase (hCA, EC 4.2.1.1) II complexed with two aromatic sulfonamides incorporating 2-thienylacetamido moieties are reported here. Although, the two inhibitors only differ by the presence of an additional 3-fluoro substituent on the 4-amino-benzenesulfonamide scaffold, their inhibition profiles against the cytosolic isoforms hCA I, II, III, VII and XIII are quite different. These differences were rationalized based on the obtained X-ray crystal structures, and their comparison with other sulfonamide CA inhibitors with clinical applications, such as acetazolamide, methazolamide and dichlorophenamide. The conformations of the 2-thienylacetamido tails in the hCA II adducts of the two sulfonamides were highly different, although the benzenesulfonamide parts were superimposable. Specific interactions between structurally different inhibitors and amino acid residues present only in some considered isoforms have thus been evidenced. These findings can explain the high affinity of the 2-thienylacetamido benzenesulfonamides for some pharmacologically relevant CAs (i.e., isoforms II and VII) being also useful to design high affinity, more selective sulfonamide inhibitors of various CAs.
PubMed: 21620713
DOI: 10.1016/j.bmc.2011.05.006
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (1.7 Å)
構造検証レポート
Validation report summary of 3r17
検証レポート(詳細版)ダウンロードをダウンロード

252456

件を2026-04-22に公開中

PDB statisticsPDBj update infoContact PDBjnumon